PRODUCTION METHOD OF FRAGMENTED EXTRACELLULAR MATRIX COMPONENT

1 . A production method of a fragmented extracellular matrix component, comprising:

a step of neutralizing a solution in which an extracellular matrix component is dissolved;

a step of obtaining a mass containing the extracellular matrix component by removing a solvent through freeze-drying treatment after the neutralization step;

a step of obtaining a liquid containing the fragmented extracellular matrix component by dispersing the mass in a solution containing a polar organic solvent and fragmenting the extracellular matrix component in the solution; and

a step of removing a liquid component from the liquid containing the fragmented extracellular matrix component.

2 . The production method according to claim 1 , further comprising:

a step of replacing the liquid component in the liquid obtained in the step of obtaining the liquid with water after the step of obtaining the liquid and before the step of removing the liquid component,

wherein, in the step of removing the liquid component, the liquid component is removed from the liquid containing the fragmented extracellular matrix component through freeze-drying treatment.

3 . The production method according to claim 2 , further comprising:

a step of subjecting the liquid containing the fragmented extracellular matrix component to ultrasonic crushing treatment after the step of performing replacement with the water and before the step of removing the liquid component.

4 . The production method according to claim 1 , further comprising:

a step of gelling the neutralized solution after the neutralization step and before the step of obtaining the mass.

5 . The production method according to claim 4 ,

wherein the mass is a porous body.

6 . The production method according to claim 1 ,

wherein the fragmentation comprises defibration of an extracellular matrix component.

7 . The production method according to claim 1 ,

wherein the concentration of the polar organic solvent in the solution containing the polar organic solvent is 20% v/v to 100% v/v.

8 . The production method according to claim 1 ,

wherein the polar organic solvent comprises ethanol.

9 . The production method according to claim 1 , further comprising:

a step of dispersing a solid matter obtained in the step of removing the liquid component in an aqueous medium.

10 . The production method according to claim 1 ,

wherein the extracellular matrix component is a collagen.

11 . The production method according to claim 10 ,

wherein the fragmented extracellular matrix component has a triple helix structure specific to a collagen.

12 . A production method of a cell structure, comprising:

a step of mixing cells with the fragmented extracellular matrix component obtained through the production method according to claim 1 ; and

a step of incubating the mixture obtained in the mixing step.

13 . A dried product of fragmented extracellular matrix components, comprising:

stacked fibrous extracellular matrix components having an average diameter of 0.08 μm to 2.0 μm.

14 . The dried product of fragmented extracellular matrix components according to claim 13 ,

wherein, in an observation image acquired by preparing a slice specimen and observing a rectangular region of the slice specimen with a long side of 1820 μm and a short side 1365 μm using a microscope, an area of a region where the extracellular matrix components are present in the area of the observation image is 40% to 100%.

15 . The dried product of fragmented extracellular matrix components according to claim 13 ,

wherein the fragmented extracellular matrix components are fragmented collagens.

16 . A fragmented extracellular matrix component, having a peak within a wavelength range of 400 nm to 550 nm as measured by fluorescence intensity using 1,8-anilinonaphthalene sulfonic acid (ANS).

17 . The production method according to claim 1 ,

wherein the average length of the fragmented extracellular matrix component is 100 nm to 400 μm.

18 . The production method according to claim 1 ,

wherein the average diameter of the fragmented extracellular matrix component is 10 nm to 10 μm.